Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jun;23(3):165-73.
doi: 10.1016/j.smim.2011.07.001. Epub 2011 Aug 11.

Immuno-intervention for the induction of transplantation tolerance through mixed chimerism

David H Sachs  1 , Megan Sykes, Tatsuo Kawai, A Benedict Cosimi
Affiliations
Review

Immuno-intervention for the induction of transplantation tolerance through mixed chimerism

David H Sachs et al. Semin Immunol. 2011 Jun.

Abstract

The induction of transplantation tolerance could liberate organ transplant recipients from the complications of life-long chronic immunosuppression. The original description of tolerance induction through mixed hematopoietic chimerism in mice utilized lethal whole body irradiation as the preparative regimen for achieving mixed chimerism. While such a regimen might be acceptable for treatment of patients with malignancies, which might also respond to the therapeutic effects of radiation, its toxicity would be unacceptable for patients in need only of an organ transplant. Graft-vs.-host disease, which is frequently a complication of mismatched bone marrow transplantation, would likewise be unacceptable for ordinary clinical transplantation. Therefore, as we have extended the use of this modality for tolerance induction from mice to large animal models, we have attempted to design preparative regimens that avoid both of these complications. In this article, we review our studies of mixed chimerism in mice, miniature swine and monkeys, as well as the results of our recent clinical studies that have extended this treatment modality to a series of kidney transplant patients who have been successfully weaned from all immunosuppression while maintaining stable renal function for up to 8 years.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Tolerance induction regimen in cynomolgus monkeys: A) The initial preparative and treatment regimens; B) Renal allograft survivals with initial regimen or with modified regimen (anti-CD154 with or without splenectomy)
Figure 2
Figure 2
Tolerance of kidneys in cynomolgus monkeys: A) Gross appearance of transplanted kidney at biopsy (normal); B) Microscopic appearance of same kidney, (normal histology); C) Frozen donor skin grafted onto thorax of recipient approximately one year after renal transplant is accepted (left), while third party skin, either fresh (top right) or frozen (bottom right) is rejected by day 15 after skin grafting.
Figure 3
Figure 3
Clinical tolerance induction regimen: Preparative and treatment regimen for HLA-matched sibling donors in first clinical trial for patients with ESRD and intractable multiple myeloma.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance to foreign cells. Nature. 1953;172:603–606. - PubMed
    1. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 1984;307(5947):168–170. - PubMed
    1. Sachs DH, Sharabi Y, Sykes M. Mixed chimerism and transplantation tolerance. In: Melchers F, et al., editors. Progress in Immunology. Vol. VII. Berlin Heidelberg: Springer-Verlag; 1989. pp. 1171–1176.
    1. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med. 1989;169:493–502. - PMC - PubMed
    1. Sykes M, Sharabi Y, Sachs DH. Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation. Bone Marrow Transplant. 1988;3:379–386. - PubMed

Publication types